A detailed history of Gerber, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gerber, LLC holds 3,960 shares of ABBV stock, worth $695,296. This represents 0.57% of its overall portfolio holdings.

Number of Shares
3,960
Previous 3,960 -0.0%
Holding current value
$695,296
Previous $679 Million 15.14%
% of portfolio
0.57%
Previous 0.53%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $18,265 - $21,329
-118 Reduced 2.89%
3,960 $679 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $32,922 - $37,512
206 Added 5.32%
4,078 $743 Million
Q4 2023

Mar 05, 2024

BUY
$137.6 - $154.97 $532,787 - $600,043
3,872 New
3,872 $600 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gerber, LLC Portfolio

Follow Gerber, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gerber, LLC with notifications on news.